Another potential side effect of repeated administration of CAR T-cells has been observed in a previous clinical study where patients receiving T-cells electroporated with anti-mesothelin mRNA CAR bearing a mouse anti-human scFv experienced anaphylaxis from the development of anti-mouse antibodies [40]. The gene discussed is MSLN; the disease is anaphylaxis.